Status:

ACTIVE_NOT_RECRUITING

Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Krabbe Disease

Eligibility:

All Genders

Up to 17 years

Brief Summary

This study is designed to learn about early brain development in children with Krabbe disease, and to use diffusion tensor imaging as an early diagnostic tool to identify newborns at risk for the dise...

Detailed Description

This study is designed to learn about early brain development in children with Krabbe disease and to use diffusion tensor imaging (DTI) as an early diagnostic tool to differentiate children with infan...

Eligibility Criteria

Inclusion

  • Positive newborn screening test (low galactocerebrosidase)
  • Infantile Krabbe Disease diagnosed by confirmatory low levels of residual enzyme by Dr. Wenger's Lysosmal Storage Diseases laboratory at Jefferson's Medical College (contracted by New York State) and/or carrier status established because of family history of Krabbe Disease. Patients have to be less than 6 weeks old at the time of the first assessment
  • Children at risk of developing motor disability

Exclusion

  • Diagnosis or physical signs of known genetic conditions or syndromes, serious medical or neurological conditions affecting growth and development (e.g., seizure disorder, diabetes, congenital heart disease) or sensory impairments such as vision or hearing loss
  • Children who may have suffered serious perinatal brain damage, children with birth weights less than 2000 grams and/or gestational ages of less than 34 weeks, or those with a history of intraventricular hemorrhage
  • Children who may have a contraindication for MRI (pacemaker, vascular stents, metallic ear tubes, other metal implants or braces).

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00787865

Start Date

April 1 2008

End Date

April 1 2027

Last Update

April 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213